This case study examines the use of advocacy to reduce newborn infections in Bangladesh, specifically the market advocacy efforts by PATH and the Bangladesh Pediatric Association to engage public and private stakeholders to understand the importance of 7.1 percent chlorhexidine digluconate use.
Corporate author(s): PATH
Publication date: December 2017
736 KB PDF
Hard copies are not available.
Some digital files may be saved at low resolutions to conserve file size. Versions with higher quality may be available; see the contact information below to enquire.
- For advocates and policymakers > Advocacy strategy
- For advocates and policymakers > Child health
- For advocates and policymakers > Public-private partnerships
- Maternal and child health > Safe birth and newborn care
For more information…
Contact: PATH Publications
Mailing address: PATH, PO Box 900922, Seattle, WA 98109 USA